ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $151M

      Shares

      13M

      % of Portfolio

      1.11%

      Average Buy Price

      $33.1

      Avg closing price
      Price range

      33 Cathie Wood Intellia Therapeutics Trades

      Cathie Wood acquired 13M Intellia Therapeutics shares worth $151M. That's 1.11% of their equity portfolio (26th largest holding). The investor owns 12.41% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares 25 more times and sold shares on seven occasions. The investor's estimated purchase price is $430M, resulting in a loss of 65%.

      Avg closing price
      Price range
      Increased shares by 0.1% (+6.86k shares) Q2 2025
      Avg closing price $8.24
      Price range $6.28 - $9.67
      Increased shares by 3.8% (+475k shares) Q1 2025
      Avg closing price $10.13
      Price range $7.11 - $12.80
      Increased shares by 2.3% (+281k shares) Q4 2024
      Avg closing price $15.50
      Price range $11.41 - $21.08
      Increased shares by 5.7% (+660k shares) Q3 2024
      Avg closing price $23.05
      Price range $19.72 - $27.36
      Increased shares by 5.5% (+607k shares) Q2 2024
      Avg closing price $23.81
      Price range $20.02 - $27.22
      Sold 3.7% shares (-423k shares) Q1 2024
      Avg closing price $27.78
      Price range $23.82 - $32.80
      Increased shares by 14.7% (+1.46M shares) Q4 2023
      Avg closing price $28.74
      Price range $23.16 - $32.34
      Increased shares by 4.4% (+423k shares) Q3 2023
      Avg closing price $38.80
      Price range $31.62 - $45.78
      Sold 3.2% shares (-311k shares) Q2 2023
      Avg closing price $40.55
      Price range $34.58 - $46.03
      Increased shares by 4.4% (+416k shares) Q1 2023
      Avg closing price $39.22
      Price range $33.30 - $44.82
      Sold 2.4% shares (-236k shares) Q4 2022
      Avg closing price $47.55
      Price range $33.21 - $62.69
      Increased shares by 1.5% (+142k shares) Q3 2022
      Avg closing price $62.04
      Price range $53.92 - $71.70
      Increased shares by 5.9% (+534k shares) Q2 2022
      Avg closing price $50.78
      Price range $38.49 - $76.21
      Increased shares by 13.4% (+1.06M shares) Q1 2022
      Avg closing price $84.72
      Price range $58.27 - $118.99
      Increased shares by 17.4% (+1.17M shares) Q4 2021
      Avg closing price $125.27
      Price range $100.76 - $138.36
      Sold 12.2% shares (-941k shares) Q3 2021
      Avg closing price $151.40
      Price range $132.37 - $176.78
      Sold 20.1% shares (-1.93M shares) Q2 2021
      Avg closing price $77.87
      Price range $60.88 - $161.91
      Sold 14.1% shares (-1.58M shares) Q1 2021
      Avg closing price $67.12
      Price range $46.59 - $83.68
      Sold 1.9% shares (-213k shares) Q4 2020
      Avg closing price $36.31
      Price range $18.83 - $63.53
      Increased shares by 0.0% (+1.37k shares) Q3 2020
      Avg closing price $20.85
      Price range $17.47 - $24.93

      News about Intellia Therapeutics Inc and Cathie Wood

      Cathie Wood''s ARK buys Intellia stock, sells Tesla and Verve

      Cathie Wood''s ARK buys Intellia stock, sells Tesla and Verve

      https://www.investing.com/news/company-news/cathie-woods-ark-buys-intellia-stock-sells-tesla-and-verve-93CH-3509465

      Investing.com Investing.com, about 1 year ago
      3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024

      3 Stocks Cathie Wood Just Bought to Get Back on Track in the Second Half of 2024

      Wood added to her positions in Palantir, Archer Aviation, and Intellia Therapeutics on Monday. Palantir is one of her largest holdings, and the big data anal...

      fool.com fool.com, about 1 year ago
      Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024

      Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for June 2024

      Investors looking for long-term returns should consider investing in strong buy Cathie Wood stocks this month. The ARK Invest Chief Executive Officer (CEO) g...

      investorplace.com investorplace.com, about 1 year ago
      Better Cathie Wood Stock: Moderna vs. Intellia

      Better Cathie Wood Stock: Moderna vs. Intellia

      Moderna and Intellia have declined in the double digits over the past year.

      The Motley Fool The Motley Fool, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×